602 related articles for article (PubMed ID: 10213494)
1. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
3. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S
Cancer Res; 1992 Aug; 52(16):4413-9. PubMed ID: 1386556
[TBL] [Abstract][Full Text] [Related]
4. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
Lane TF; Leder P
Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
Alexander CM; Reichsman F; Hinkes MT; Lincecum J; Becker KA; Cumberledge S; Bernfield M
Nat Genet; 2000 Jul; 25(3):329-32. PubMed ID: 10888884
[TBL] [Abstract][Full Text] [Related]
6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
Cui XS; Donehower LA
Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
[TBL] [Abstract][Full Text] [Related]
8. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T; Varmus HE; Donehower LA
Cell Growth Differ; 1997 Aug; 8(8):829-38. PubMed ID: 9269892
[TBL] [Abstract][Full Text] [Related]
9. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
Schroeder JA; Troyer KL; Lee DC
Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
[TBL] [Abstract][Full Text] [Related]
10. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
Li YX; Papkoff J; Sarkar NH
Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
[TBL] [Abstract][Full Text] [Related]
11. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
[TBL] [Abstract][Full Text] [Related]
12. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
13. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
Edwards PA; Hiby SE; Papkoff J; Bradbury JM
Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
[TBL] [Abstract][Full Text] [Related]
14. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
15. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
16. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
[TBL] [Abstract][Full Text] [Related]
17. Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse.
Marino S; Romelfanger C; Yokota Y; Nusse R
BMC Cancer; 2004 Dec; 4():91. PubMed ID: 15601467
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
19. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
Devanesan P; Santen RJ; Bocchinfuso WP; Korach KS; Rogan EG; Cavalieri E
Carcinogenesis; 2001 Sep; 22(9):1573-6. PubMed ID: 11532882
[TBL] [Abstract][Full Text] [Related]
20. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
